ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2021 Congress

July 17-21, 2021. Philadelphia, PA.

View by Title View by Number View Themes
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: PB1040

    A 3D in vitro Model of Inflammation-associated Bleeding

    R. Riddle1, K. Hansson2, K. Jennbacken2, M. Harper1

  • Abstract Number: PB0784

    A 5-Year Study of Arterial and Venous Thromboses in Greek Infants, Children and Adolescents. Comparison of Data Before and during the Pandemic Period

    L. Ioannidou1, A. Dettoraki1, A. Michalopoulou1, Z. Kapsimali1, S. Saslis1, M. Mazarakis1, H. Pergantou1

  • Abstract Number: PB0624

    A Bleed Suppression Efficacy of Emicizumab in Patients with Hemophilia A whose Therapies Switched from Conventional Prophylaxis

    T. Fujii1, N. Yamasaki1, T. Inoue1, T. Fujii1

  • Abstract Number: OC 48.1

    A Blood Coagulation Factor IX Variant that Functions Independently of Factor VIII Mitigates the Hemophilia A Phenotype in Patient Plasma

    V.J. Strijbis1, L.G. Romano2, K.L. Cheung1, Y.P. Liu3, A.C. McCreary3, F.W. Leebeek2, M.H. Bos1

  • Abstract Number: PB0807

    A Case of a Pediatric Patient with Protein S Heerlen Polymorphism and Deep Venous Thrombosis

    M. Kacar1, M. Bhatt1

  • Abstract Number: PB0408

    A Case of Congenital Afibrinogenemia with Two Successful Spontaneous Delivery After Recurrent Pregnancy Losses

    M. Mastanzade1, M.M. Özbalak1, S. Kalayoğlu Beşışık1

  • Abstract Number: PO117

    A Case of Recurrent Myocardial Infarction and Heterozygous Factor V Leiden

    E. Grinsztejn1, J.P. Dugan1, E.X. Stavrou2,3

  • Abstract Number: PB0812

    A Case Report and Comprehensive Review of Acquired Purpura Fulminans in Children

    S. Zarb1, A.K. Chan2, V. Price3, M.D Bhatt2

  • Abstract Number: PB1072

    A Comparative Cohort Study of Serum Rivaroxaban Levels in Singaporean (SG) and British (UK) Non-valvular Atrial Fibrillation (NVAF) Patients

    E.X. Yong1, Y.Y. Lin2, D. Tan1, E. Chan1, V. Speed3, J. Patel3, E.S. Yap4, G. Chang2, P. Gallagher1

  • Abstract Number: PB0080

    A Comparative Study of SEER Sonorheometry versus Thromboelastography during Cardiac Surgery with Cardiopulmonary Bypass

    A. Abbes1, C. Frere1,2, J. Loeb1, N. Djavidi1, G. Lebreton1,2, A. Bougle1,3

  • Abstract Number: PB0984

    A comparison of Five Platelet Reactivity Tests in Over 3,000 Participants of the Framingham Heart Study

    M.V. Chan1, M.-H. Chen1, F. Thibord1, A. Lachapelle1, J. Grech1, P.C.J. Armstrong2, T.D. Warner2, A.D. Johnson1

  • Abstract Number: PB0364

    A Comparison of Functional Methods with Absolute Quantification of Heparin Levels in Clinical Samples by Heparin Red Assay

    E. Bontekoe1, F. Siddiqui1, D. Hoppensteadt1, A. Kouta1, J. Fareed1, R. Kraemer2

  • Abstract Number: PB1073

    A Comparison of the Incidence of Traumatic Brain Injury in Anticoagulated and Non-anticoagulated Head Injured Patients

    F. Al-Haimus1, N. Clayton1,2, J. Klyn2, K. de Wit3,1

  • Abstract Number: PB0810

    A Comprehensive Review of Tumour Thrombus in Pediatric Wilms Tumour Patients

    K. Kwok1, A.K. Chan1, M.D Bhatt1, N. Samji1

  • Abstract Number: PB0781

    A Conservative Therapy Spontaneous Intracranial Hemorrhage in a Pediatric Patient with Severe Acquired Aplastic Anemia

    M.-M. Deveza1, A. Rodrigues1, T. Quaresma1, C. Peixoto1, A. Ferrão2

  • Abstract Number: PB0003

    A Coupled 1D-3D Hybrid Model for Patient-specific Coronary Flow Simulations: Bridging the Gap between Macroscale Hemodynamics and Microscale Thrombosis Models

    N. Grande Gutierrez1, T. Sinno1, S. Diamond1

  • Abstract Number: PB1057

    A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter

    C. Farkh1, S. Ellouze1, L. Gounelle1, M. Sad-Houari1, J. Duchemin1, V. Proulle1, M. Fontenay1,2, X. Delavenne3,4, G. Jourdi1,5,6,7

  • Abstract Number: OC 74.2

    A Heterozygous Mutation in SLFN14 Influences Species-specific Haematopoietic Regulation in Platelet and Erythroid Lineages

    R. Stapley1, C. Smith1, E. Haining1, A. Bacon2, S. Lax3, V. Pisareva4, A. Pisarev4, S. Watson1,5, A. Khan1, N. Morgan1

  • Abstract Number: PB0002

    A Machine-learning-Based Bio-psycho-Social Model for the Prediction of Non-obstructive and Obstructive Coronary Artery Disease

    V. Raparelli1, M. Proietti2, G.F. Romiti3, R. Seccia4, G. Di Teodoro4, G. Tanzilli5, R. Marrapodi3, B. Corica3, D. Flego3, R. Cangemi3, L. Palagi4, S. Basili3, L. Stefanini3

  • Abstract Number: PB1287

    A Major Knowledge Gap in Women’s Health: The Combined Effect of Antifibrinolytics and Estrogen on Risk of Thromboembolism – A Scoping Review

    D. Meschino1,2, D. Lindsay2,3, G. Tang2,1,4, P. James5,6, M. Sholzberg2,1,4

  • Abstract Number: OC 35.4

    A Major Reservoir for Heparin-releasable TFPIα is Extracellular Matrix

    J. Peterson1, S. Maroney1, N. Martinez1, A. Mast1

  • Abstract Number: OC 54.1

    A Mechanism for Hereditary Angioedema Caused by a plasminogen Lys311Glu Substitution

    SK. Dickeson1, S. Kumar1, M.-F. Sun1, B.M Mohammed1, Q. Cheng1, I. Ivanov1, J.C Whisstock2, A.J Quek3, E.P Feener4, D.R Phillips5, R.HP Law2, D. Gailani1

  • Abstract Number: OC 16.4

    A Mouse Model of Protease Activated Receptor 4 (PAR4) variant rs2227376 Has Reduced Platelet Reactivity to Physiological Doses of Thrombin

    X. Han1, M. de la Fuente1, E. Knauss1, M. Nieman1

  • Abstract Number: PB1230

    A Multi-disciplinary Approach to Improving Temporary IVC Filter Retrieval Rates

    J. Kamp1, T. Ammar1, J. Wilkins1, L. Roberts1

  • Abstract Number: PB0821

    A Multicenter Double-blind, Double-dummy, Randomized Study of rhTPO vs Eltrombopag in the Treatment of Chinese Immune Thrombocytopenia

    H. Mei1, M. Xu1, G. Yuan2, F. Zhu3, J. Guo4, R. Huang5, J. Qin6, T. Lv2, F. Qin3, H. Cai4, P. Yin7, T. Qin7, Y. Hu1

  • Abstract Number: PB0857

    A Multicenter Retrospective Evaluation of Direct Oral Anticoagulants for the Treatment of Heparin Induced Thrombocytopenia

    K. Davis1, J. Sebaaly2, L. Wooten3, C. Khouli4, A. Mihm1, S. Nisly1,5

  • Abstract Number: LPB0130

    A Multiscale Framework for Patient-specific Predictions of Thrombus Growth

    K. Shankar1, T. Sinno1, S. Diamond1

  • Abstract Number: PB1286

    A New Pharmacodynamic Test to Evaluate Effects of Oral Contraceptives on Coagulation

    P. de Kruijf1, S. Naji1, C. Krijnen1, J. Jespersen2, C. Kluft1

  • Abstract Number: PB0904

    A Novel Disease-causing Variant in the GP1BA Gene Related to Bernard Soulier Syndrome

    A.I. Woods1, M.F. Alberto2, D.M. Primrose3, J. Paiva4, M. Asencio4, M.M. Casinelli4, A.N Blanco4, A. Sánchez-Luceros4,5

  • Abstract Number: PB0880

    A Novel Dual AntiPlatelet and AntiCoagulant APAC: Interaction Between Platelet Factor 4 (PF4) and APAC Decreases Functional Activity

    I. Nevzorov1, A. Jouppila2, R. Lassila3,4

  • Abstract Number: PB1055

    A Novel ELISA Assay for the Detection of Anti-prothrombin Antibodies in APS Patients at High Risk of Thrombosis

    N. Pozzi1, V. Pengo2

  • Abstract Number: PB0896

    A Novel Hemizygous Variant in GATA1 Associated with Bleeding Diathesis and Platelet Dysfunction in Two Unrelated Patients

    J.M. Bastida1,2,3,4, D. Boeckelmann5,6, V. Palma-Barqueros7,8, M. Wolter5,6, M.L Lozano7,8, H. Glonnegger5,6, R. Benito2,3, F.H Schilling9, N. Morgan10, K. Freson11, J. Rivera7,8,4, B. Zieger5,6

  • Abstract Number: PB0029

    A Novel Mouse Model for Cerebral Venous Thrombosis

    M.-C. Bourrienne1, S. Loyau1, S. Benichi2, J. Gay1, M. Solo-Nomenjanahary1, D. Faille1,3, C. Journé4, L. Di Meglio1, A. Freiherr von Seckendorff1, J.-P. Desilles1,5, B. Ho-Tin-Noé1, M. Mazighi1,5,6, N. Ajzenberg1,3

  • Abstract Number: PB0342

    A Novel Paper-based Test for Diagnostic of Fibrinogen Levels on Whole Blood

    A.T. Sachetto1, N.T. Picon2, C.B. Morgado2, M. L. Santoro1

  • Abstract Number: OC 61.3

    A Novel Particle-based Model Delivers Mechanistic Insights into Arterial Thrombus Heterogeneity

    A.A. Masalceva1,2, V.N. Kaneva1,2,3, M.A. Panteleev1,2,3,4, F.I. Ataullahanov1,2,3,4, V. Volpert5,6,7, I.V. Afanasyev8,9, D.Y. Nechipurenko1,2,3

  • Abstract Number: OC 05.3

    A Novel Prediction Platform to Enhance the Design of Therapeutic SERPINs

    W. Sanrattana1, T. Sefiane2, S. Smits1, M. Fens3, D. Monroe4, P. Lenting2, C. Maas1, S. de Maat1

  • Abstract Number: PB0650

    A Novel Strategy for Platelet-specific Gene Therapy for the Treatment of Hemophilia A via Intranasal Delivery Lentiviral Vectors Containing Factor VIII

    C.W. Rementer1, C. Li1, C.-Y. Chen1, C.H. Miao1

  • Abstract Number: PB0971

    A Novel Therapeutic Strategy for Hepatocellular Carcinoma Based on the Tumor-platelet Interaction

    H. Tanaka1, K. Horioka2

  • Abstract Number: PB0402

    A Patient with Congenital Hypofibrinogenemia who Showed Embryo Implantation, Continuation of Pregnancy, and Delivery Following Continuous Transfusion of Dry Human Fibrinogen Preparations

    Y. Seki1, T. Ushiki2, M. Masuko3, J. Takizawa3, H. Sone3, N. Okumura4

  • Abstract Number: PB1121

    A Population-Based Descriptive Study of Long-term Anticoagulation in the Treatment and Secondary Prophylaxis of Venous Thromboembolism in Men with Prostate Cancer in Sweden

    Y. Balabanova1, B. Farahmand2, P. Stattin3, H. Garmo3, G. Brobert2

  • Abstract Number: PB1155

    A Potential Risk of Venous Thrombosis Induced by Nanomaterials and the Protection Role of Nrf2

    Y. Bian1,2, J. Pi1

  • Abstract Number: PB1068

    A Prolonged Actived Partial Thromboplastin Time Revealing a Childhood Systemic Lupus erythematosus

    I. Krichen1, S. Samet1, F. Megdich1, M. Hsairi2, L. Gargouri2, A. Mahfoudh2, C. Kallel1

  • Abstract Number: PB0640

    A Prospective Cohort Study on Disabilities in Patients with Haemophilia Using Orthopaedic Scores

    M. Bajracharya1, B.S. Poudyal1, S. Marahatta1, S. Rayamajhi1, V. Prajapati1, C.D.K. Mahato1

  • Abstract Number: PB0450

    A Prospective Comparison Study of the Diagnosis of Disseminated Intravascular Coagulation (DIC) Comparing Between ISTH DIC Scoring system and General Practice in Prediction of 28-day Mortality

    T. Thamgrang1, C. Sirisuksakun1, K. Prayongratana1

  • Abstract Number: PB0806

    A Prospective Data Collection Utilizing the International Pediatric Thrombosis Network (IPTN) to Understand the Epidemiology for the Development of Neonatal Renal Vein Thrombosis

    G. Woods1, J. Motwani2, N. Sirachainan3, R. Berrueco4, C.H. van Ommen5, A.KC Chan6

  • Abstract Number: PB0863

    A Puzzling HIT History: HIT Associated with Fondaparinux or True Autoimmune HIT?

    N. Sillamy1, C. Vayne1,2, J. Rollin1,2, M. Desailly1, M. Navarro3, J.-B. Valentin1, C. Pouplard1,2, Y. Gruel1,2

  • Abstract Number: PB0586

    A Qualitative Study on the Experiences of Hemophilia Carriers before, during and after Pregnancy

    M.C. Punt1, L. Teela2, K. Fischer1, K.W.M. Bloemenkamp3, A.T. Lely3, M.H.E. Driessens4, L. Pekel4, L. Haverman2, K.P.M. van Galen1.

  • Abstract Number: PB0933

    A Quantitative Evaluation of vWF Multimeric Structure in Patients with Different Types of vWD and aVWS

    A. Poletaev1, E. Seregina1,2, N. Karamyan1, P. Zharkov1

  • Abstract Number: OC 60.1

    A Randomized, Double-blind, Placebo-controlled, Phase 2 Study Evaluating Safety and Efficacy of AB023 in Hemodialysis Patients

    C. Lorentz1,2, E.I. Tucker1,2, N.G. Verbout1,2, J.J. Shatzel2, S.R. Olson2, B.D. Markway1, M. Wallisch1,2, M. Ralle2, M.T. Hinds2, O.J. McCarty2, D. Gailani3, J.I. Weitz4, A. Gruber1,2

  • Abstract Number: PO165

    A Rare Case of Bi-atrial Thrombi in a Stage IV Pancreatic Cancer Patient with Atrial Fibrillation on Warfarin

    K.Y. Kim1, N.H. Kim1, T. Alrifai2

  • Abstract Number: PB0801

    A Rare Case of Thrombotic Storm in Henoch-Schonlein Purpura

    A.K. Baylon1, H.P. Tan1, M.L. Naranjo1, C. Fernandez1, R. Anastacio1, C.R. Castro1

  • Abstract Number: PB0005

    A Rare Presentation of ST-segment Elevation Myocardial Infarction Associated with Ovarian Stimulation in the Absence of Ovarian Hyperstimulation Syndrome

    K.Y. Kim1, Y. Gerais1, A. Prasad1, N.H. Kim1, C. Sun1, S. Hussein1, P. Thapa1, R. Ramadurai2

  • Abstract Number: PB1256

    A Real-world Experience of Venous Thromboembolism (VTE) Management in Australia

    B. Lui1, A. Kwok2, J. Lai2, Z. Khattak1, P. Ho1, H.Y. Lim1,2

  • Abstract Number: PB1272

    A Realist Evaluation on Therapeutic Elastic Compression Therapy Pathways for DVT- and CVD Patients to Develop Evidence-informed Improvement Strategies

    R.H. Schreurs1,2,3, M.A. Joore4, D. De Bruijn-Geraets4, H. Ten Cate1,2,3, A.J. Ten Cate-Hoek1,2

  • Abstract Number: PO156

    A Refractory Thrombotic Thrombocytopenic Purpura Case Complicated by Hepatic Sinusoidal Obstruction Syndrome and Successful Management with Defibrotide

    S. Erdem1, M. Mastanzade1, S. Altay-Dadin2, M. Yanasik3, S. Kalayoglu-Besisik1

  • Abstract Number: PB1249

    A Retrospective Evaluation of the Management of Isolated Distal Deep Vein Thrombosis in Australia

    B. Lui1, J. Lai2, Z. Khattak1, A. Kwok2, P. Ho1, H.Y. Lim1,2

  • Abstract Number: PB0776

    A Retrospective Review of Diagnosis and Management of Heavy Menstrual Bleeding and Co-morbidities in Patients Seen in Young Women’s Blood Clinic

    D. Desai1, M. Joshi1, R. Upadhyay1, D. Costescu1, M. Bhatt1

  • Abstract Number: PB0491

    A Review Following Implemented Training for Health Care Practitioners in Primary Care Settings of Immunisation Practice in Children with Bleeding Disorders

    M. Eales1, A. Wilkinson1, S. Pool2, G.W Hall1, N. Bhatnagar1

  • Abstract Number: PB0703

    A Review of Beighton Scores Recorded for All Patients with a Bleeding Tendency Registered at One Haemophilia Centre without Another Formal Bleeding Disorder Diagnosis

    J. Clark1, D. Stephensen1, C. Dodd1, K. Elliott1

  • Abstract Number: PB0751

    A Role of Possible Synergistic Effect of P Selectin Glycoprotein Ligand 1 Polymorphism and Antiphosholipid Antibodies on Thrombosis in Myeloproliferative Neoplasia Patients

    R. Dambrauskienė1, R. Gerbutavičius1, R. Vadeikienė1, R. Gerbutavičius2, R. Ugenskienė1, M. Rudžianskienė1, E. Juozaitytė1, D. Remeikienė1, R. Gerbutavičienė3, R. Paukštaitienė4

  • Abstract Number: PB1025

    A rRle for the JAK/STAT5 Axis in GPVI-mediated Platelet Function

    I. Parra Izquierdo1, A. R. Melrose1, J. Pang1, S.H. Vasilipalli1, S. E. Reistma1, H.H. Sudhan Lakshmanan1, M. K. Larson2, O. J.T. McCarty1, J. E. Aslan1

  • Abstract Number: PB0663

    A Savvy Approach to Clinical Trial Recruitment for the SAAVY (Seroprevalence of AAV AntibodY) Study in the Era of COVID-19: Designing for a Prospective, Observational Study in the United States during a Global Pandemic

    L.A. Valentino1, M. Vaghela2, M. Lauw2, G. Dela Cerda2, M. Jones2, D. Hinds2, V. Newman2, F. Leal-Pardinas2, D. Rotellini1, K. Schafer3, G. Pierce4, S. Pipe5,6

  • Abstract Number: PB0321

    A Service Evaluation of Prothrombin Complex Concentrate Use and Safe Administration Procedures in a Tertiary Hospital and Trauma Centre

    M. Robinson1, C. Hickman1

  • Abstract Number: LPB0098

    A Simple Score to Evaluate Bleeding Risk in Medical Patients Taking Antiplatelets for Cardiovascular Prevention

    S. Barbar1, A. Vecchiato2, F. Moro2, F. Boscaro2, F. Fabris2

  • Abstract Number: PB1182

    A Simplified Decision Rule to Rule out Deep Vein Thrombosis Using Clinical Assessment and D-dimer

    K. Xu1, K. de Wit2,3, G.-J. Geersing4, T. Takada4, R. Schutgens4, J. Elf5, C. Kearon2,3, S. Parpia6,7.

  • Abstract Number: PB0533

    A single center study of bone mineral density in adult patients with severe Haemophilia A and correlation with markers of bone metabolism

    H. Ivanova1, Z. Grudeva-Popova1, T. Deneva1, N. Mateva2,2

  • Abstract Number: OC 14.2

    A Single-domain Antibody Anti-protein Z Dependent Protease Inhibitor Improves Thrombin Generation in Hemophilia

    C. Auditeau1, T.S. Nguyen1, C. Repérant1, S. Daramé1, F. Saller1, D. Borgel1,2, E. Bianchini1

  • Abstract Number: LB 01.3

    A Six-week versus Three-month Duration of Anticoagulation for Acute Provoked Venous Thromboembolism in Patients < 21 Years Old: Results of the Multinational Kids-DOTT Randomized Controlled Trial

    N.A. Goldenberg1,2, S. Schulman3, J.M. Kittelson4, T.C. Abshire5,6, M. Bonaca4,7, J.F. Casella8, R.A. Dale7, J.L. Halperin9, F. Hamblin2, C.M. Kessler10,11, M.J. Manco-Johnson4, R.F. Sidonio12,13, A.C. Spyropoulos14,15,16, P.G. Steg17, A.G.G. Turpie3, W.R. Hiatt4,7, Kids-DOTT Trial Investigators§ and the ATLAS Group

  • Abstract Number: PB0628

    A Study of Psychosocial Issues for Mothers of Children with Hemophilia

    A. Nakao1, J. Yamanouchi1

  • Abstract Number: PB1270

    A Survey of Current Anticoagulation Patient Education Practices and Development

    A. Jones1, J. Saunders2, S. Vazquez3, A. Fagerlin1, D. Witt2

  • Abstract Number: PB0367

    A Systematic Review and Meta-analysis of Performances of Prototype and Commercial DOAC Dipstick Tests for Detecting Direct Oral Anticoagulants in Patient Urine Samples – Increasing Confidence for Testing in Emergency Care

    A. Martini1, R. Bauersachs2, J. Beyer Westendorf3, M. Crowther4, J. Douxfils5,6, I. Elalamy7, J. Harenberg8,9, S. Hetjens1, C. Weiss1

  • Abstract Number: PB1223

    A Systematic Review and Meta-analysis on the Use of Chemoprophylaxis in the Prevention of Venous Thromboembolism in Colorectal Cancer Surgery in Asian Population

    S.J.J. Tan1, A.Y. Chok1, Y.Y. Ng1, I. Seow-En1, R. Sultana2, J.C. Allen2, E.K.W. Tan1, R. Mathew1.

  • Abstract Number: PB0682

    A Systematic Review on the Pharmacokinetics and Associated Pharmacodynamics of Emicizumab in Humans

    A. Donners1, C. Rademaker1, L. Bevers1, A. Huitema1,2,3, R. Schutgens1, A. Egberts1,4, K. Fischer1

  • Abstract Number: OC 47.2

    A Thrombospondin-1 Release Assay (TRA) Coupled to PF4-treated Frozen Platelets is Highly Accurate for the Detection of Pathogenic HIT Antibodies: Implications for Development of a Near-patient HIT in vitro Diagnostic Assay

    A. Padmanabhan1, B. Singh1, C. Jones2, R. Leger1, R. Pruthi1, N. Heikal1, D. Chen1

  • Abstract Number: OC 27.4

    A Unique Loop Structure in the A2-domain of Pseudonaja textilis Factor Va Prevents Activated Protein C-catalyzed A2-domain Dissociation

    M. Schreuder1,2, X. Liu3, K.L. Cheung1, P.H. Reitsma1,4, G.A.F. Nicolaes3, M.H.A. Bos1

  • Abstract Number: PB0186

    A Weight-based Approach to Thromboprophylaxis Dosing for Medical Inpatients with COVID-19

    R. Price1, Z. Kirkham1,2, A. Szuman1, S. Ahmed3, C. Macaulay4, K. Talks5, B. Greystoke5, K. Musgrave2,5

  • Abstract Number: OC 75.4

    AAV Delivery of a Novel Human Factor VIII Variant with Improved Secretion Results in Higher FVIII Expression in Hemophilia A Dogs

    G. Nguyen1, E. Merricks2, T. Long2, K. Ponder3, T. Nichols2, D. Sabatino1

  • Abstract Number: OC 69.3

    Abdominal Thromboses in Pediatric Patients: What Do we Know?

    S. Kuldanek1, A. Chan1, D. Thornhill1, L. Jacobson1, C. Baird1, J. Smith1, R. Shearer1, M. Manco-Johnson1,1

  • Abstract Number: LB 01.2

    Abelacimab for Prevention of Venous Thromboembolism

    P. Verhamme1, A. Yi2, A. Segers3, J. Salter2, D. Bloomfield2, H. Buller4, G. Raskob5, J. Weitz6

  • Abstract Number: PB0954

    Aberrant Expression of Lnc-MEG3 and Lnc-NOTCH1 Predicts Refractory Phenotype in Chronic Idiopathic Thrombocytopenic Purpura

    N. El-Khazragy1,2, S. Matbouly3, H.F. Abdelsamee4

  • Abstract Number: PB0095

    Ability of Fibrin Monomers and Fibrinogen Levels to Predict In-hospital Mortality in Patients with Severe Trauma

    T. Nguyen1, N. Tran2, T. Tran2, D. Nguyen1, N. Thang1, T. Nguyen1, T. Tran1

  • Abstract Number: PB1153

    Abnormal Thrombin Generation in Children with Thrombosis

    S. Kuldanek1, D. Thornhill1, L. Jacobson1, C. Baird1, A. Chan1, J. Smith1, R. Shearer1, M. Manco-Johnson1

  • Abstract Number: PB1141

    ABO Blood Groups as a Risk Factor for the Development of Deep Vein Thrombosis of the Lower Extremities in Elderly and Senile Patients

    A. Tomchenko1, A. Chechulova1, V. Soroka1, S. Nokhrin1, I. Khomchuk1

  • Abstract Number: LPB0099

    Absence of CCR5/CCL5 Axis Inhibits Thrombus Resolution through Reduced uPA, tPA and VEGF Expressions in DVT Model

    M. Nosaka1, Y. Ishida1, A. Ishigami1, Y. Kuninaka1, H. Yamamoto1, E. Shimada1, Y. Hashizume1, M. Kawaguchi1, A. Kimura1, N. Mukaida2, T. Kondo1.

  • Abstract Number: PB0032

    Absolute Measurement of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics

    W. Jeske1, A. Kouta1, D. Hoppensteadt1, L. Cera1, R. Duff1, J. Fareed1, R. Kraemer2

  • Abstract Number: PB1081

    Accounting of Symptoms and Ejection Fraction May Improve Prediction of Left Atrial Thrombus in Patients with Non-valvular Atrial Fibrillation before Catheter Ablation or Cardioversion

    I. Zaigraev1, I. Yavelov1, O. Drapkina1, E. Bazaeva1

  • Abstract Number: PB0190

    ACE2, ACE and Thromboinflammation in COVID-19

    A. Lundström1, L. Ziegler1, S. Havervall1, A.-S. Rudberg1, F. Von Meijenfeldt2, T. Lisman2, N. Mackman3, P. Sandén1, C. Thålin1

  • Abstract Number: PB1026

    Acetyl-CoA Carboxylase Inhibition Alters Tubulin Acetylation and Aggregation in Thrombin-stimulated Platelets

    M. Octave1, L. Pirotton1, A. Ginion1, V. Robaux1, S. Lepropre1, S. Kautbally1, V. Darley-Usmar2, J. Ambroise3, B. Guigas4, M. Giera4, M. Foretz5, L. Bertrand1, C. Beauloye1, S. Horman1

  • Abstract Number: PB0442

    Acquired Haemophilia A – Data from a Regional Blood Center in Rio de Janeiro, Brazil

    P.H.J. Santos1, M.H. Cerqueira1, M.M. Loureiro2

  • Abstract Number: PB0447

    Acquired Hemophilia A – Misdiagnosis and Possible Hazards: A Case Report

    D. Carneiro-Leão1, C. Santos1, J. Sousa Silva2, F. Correia1, S. Nobre Fernandes1, M. Carvalho1, M. Lopes1, C. Koch1

  • Abstract Number: PB0449

    Acquired Hemophilia A as a Complication of Multiple Myeloma

    A. Hoppe1, J. Rupa-Matysek1, L. Gil1

  • Abstract Number: PB0443

    Acquired Hemophilia A Presenting as Spontaneous Intramuscular Hematomas

    S. Ahmed1, E. Joseph1, K. Loughry1

  • Abstract Number: PB0448

    Acquired Hemophilia A: Pediatric Case Report

    L. Velazquez Marmolejo1, A.M. Moreno Gonzalez1, L.M. Munoz Juarez Diaz1, M.J. Garcia Tevera1, B.L. Ventura Lopez1, García Tevera María José, Moreno González Aida Mashenka, Muñoz Juárez Díaz Lucia Mariana, Velázquez Marmolejo Lizette, Ventura López Brenda Lissette.

  • Abstract Number: PB0446

    Acquired Hemophilia after Chemotherapy: Oxaliplatin and Capecitabine, a Case Report

    M. Mijares1, K. Pena1, L. Carmona1, V. Vega1, L. Puente1, S. Aranda1

  • Abstract Number: PB0739

    Acquired Isolated FVII Deficiency in Oncological Patients

    N. García-León1, M.T. Calderón-López1, S. Gómez-Arevalillo Hidalgo1, P. Martín-Serrano Martín1, A. Matilla-García1

  • Abstract Number: OC 01.4

    Acquired Platelet GPVI Signaling Deficiency Occurs Early in Patients with Gram-Positive or Gram-negative Sepsis

    L.J. Weiss1, G. Manukjan1, M. Weigel1, N. Winter1, M. Kredel2,3, B. Nieswandt1,4, D. Weismann5, H. Schulze1

  • Abstract Number: PB0952

    Acquired von Willebrand Disease

    M. Escobar1, K. Chong2, N. Montanez1

  • Abstract Number: PB0804

    Acquired von Willebrand Disease in a Child as Leading Symptom of Systemic Lupus Erythematosus

    F. Achini-Gutzwiller1, K. Ruchti1, G. Spartà1, K. Ruoss1, S. Prader1, J. Pachlopnik Schmid1, J.A. Kremer2, S. Palmer Sarott1, M. Albisetti1

  • Abstract Number: OC 40.2

    Acquired von Willebrand Disease in Pediatric Patients Undergoing ECMO Support

    J. Drop1,2, E. Wildschut2, M. de Hoog2, M. de Maat3, CH. van Ommen1

  • Abstract Number: PB0938

    Acquired von Willebrand Disease: The Diagnosis and Management of an Underdiagnosed Coagulopathy

    A. Ferretti1, E. Baldacci1, S. Lancellotti2, M. Basso2, F. Barone2, A. Pallotta3, G. Lapietra1, M. Sacco2, A. Chistolini1, E. De Candia2, C. Santoro1

  • Abstract Number: PB0888

    Acquired δ-Storage Pool Disorder Co-existing with Acquired Factor V Deficiency in Myelodysplastic Syndrome / Myeloproliferative Neoplasm

    R. Dave1, J. Mammen1, T. Geevar1, J. Rasalam1, R. Vijayan1, A. Samuel1, S. Singh1, S. Nair1, L. Mathew1

  • Abstract Number: LPB0051

    ACTIMIS Trial: Safety Interim Analysis Data of Glenzocimab, a Novel Antiplatelet Agent on Top of Acute Ischemic Stroke Standard of Care

    M. Mazighi1, A. Peeters2, S. Richard3, C. Molina4, R. Lemmens5, D. Toni6, Y. Plétan7, M. Jandrot-Perrus8, A. Comenducci7, G. Avenard7, P. Lyrer9, M. Kohrmann10, ACTIMIS Study Group

  • Abstract Number: PB0356

    Activated charcoal can be used as an effective in vitro removal agent of direct oral anticoagulants dabigatran, rivaroxaban and apixaban in plasma of patients with protein S activity testing

    S. Margetić1, I. Ćelap1, J. Buben2, M. Razum1, S. Šupraha-Goreta3

  • Abstract Number: PB1161

    Activated Charcoal to Remove DOAC from Patients’ Plasma. Potential Usefulness for Routine Coagulation and Thrombophilia Testing in DOAC Treated Patients

    M. Vannini1, B. Dahmani2, A. Appert-Flory1, F. Fischer1, D. Jambou1, P. Toulon1

  • Abstract Number: LPB0053

    Activated FVIII Inactivation Occurs Outside of the Intrinsic Xase Complex

    A. Wilhelm1, L. George1,2,3

  • Abstract Number: LPB0087

    Activated Platelets Transfer miR-223 into Endothelial Cells via Microparticles to Downregulate ICAM-1 Expression among Septic Conditions

    B. Szilágyi1, Z. Fejes1, Á. Rusznyák2, F. Fenyvesi2, M. Pócsi1, S. Halmi3, Z. Griger3, S.P. Kunapuli4, J. Kappelmayer1, B. Nagy Jr.1

  • Abstract Number: LPB0007

    Activated Protein C (APC) Resistance in FV-W1920R (FV-NARA) Was Caused by the Defective Association between FV-W1920R and Protein S (PS) in the APC/PS/FVa Assembly

    N. Shimonishi1, K. Ogiwara1, J. Yoshida1, K. Horie1, K. Nogami1

  • Abstract Number: PB0731

    Activated Protein C Impacts Survival and Activity of Mast Cells and Neurons via the Modulation of Nuclear Factor-κB Activation

    L. Gorbacheva1,2, A. Ivanova1

  • Abstract Number: LPB0017

    Activation Mechanism Dependent Surface Exposure of Cellular FXIII on Platelets and Platelet Microparticles: Immunofluorescence and Immune Electron Microscopic Study

    L. Somodi1, H. Bárdos2, I. Beke Debreceni3, G. Kis4, J. Kappelmayer3, M. Antal4, L. Muszbek1

  • Abstract Number: LPB0090

    Active Cancer and Venous Thromboembolism: Safety and Effectiveness of Edoxaban in Patients from the Noninterventional Global ETNA-VTE Program

    A. Cohen1, M. Nakamura2, K.-M. Chiu3,4, W.-I. Choi5, P.-E. Reimitz6, W. Jiang7, C. Chen7, M. Unverdorben7, G. Agnelli8

  • Abstract Number: OC 11.3

    Active Sorting of Platelets and Red Blood Cells in Contracting Blood Clots is Driven by Platelet-generated Forces that Stiffen Fibrin

    V. Tutwiler1,2, X. Chen1, R.I. Litvinov1,3, R. Khismatullin1,3, J. Kaufmanova1, C. Nagaswami1, J.W. Weisel1, V.B. Shenoy1

  • Abstract Number: LPB0031

    Activity and Cleavage of von Willebrand Disease Type 2B Variants

    M. Brehm1, Y. Yildiz2, T. Obser1, A. Mojzisch1, S. Peine3, S. Schneppenheim4, U. Budde4, R. Schneppenheim5

  • Abstract Number: PB0299

    Acute Liver Necrosis in a Sars-Cov-2 Positive Patient with Triple Positive Antiphospholipid Syndrome

    V. La Mura1,2, R. Gualtierotti1,3, I. Martinelli1, B. Ferrari1, A.M. Ierardi4, N. Bitto1, G. Ghigliazza1, A. Giachi1, M. Maggioni5, M. Cugno1,3, A.L. Fracanzani3,6, G. Carrafiello4,7, F. Peyvandi1,3

  • Abstract Number: PB0493

    Acute Myelogenous Leukemia in a Patient with Mild Haemophilia A. A Case Report at Hospital Infantil de México Federico Gómez

    L.M. Muñoz Juárez Díaz1, A.M. Moreno Gonzalez1, L. Velázquez Marmolejo1

  • Abstract Number: PB0732

    Acute Promyelocytic Leukaemia with Anti Phospholipid Antibody Syndrome – Double Trouble

    S.L. Koulmane Laxminarayana1, S. Belurkar1

  • Abstract Number: PB1198

    Acute VTE in HIV versus Non-HIV population – Nationwide Analysis of Mortality, Morbidity, Demographics and Healthcare Utilization

    M.J. Tariq1, M.U. Almani1, J. Tufail2, M.A. Elsebaie1, B. Baral1, M. Usman1, S. Gupta1

  • Abstract Number: OC 43.4

    ADAMTS-13/VWF Ratio as Biomarker for Portal Vein Thrombosis (PVT) Development in Cirrhotic Patients: A Prospective Study

    R. De Cristofaro1,2, M. Sacco2, S. Lancellotti1, M. Tardugno2, A. De Magistris3, M. Basso1, A. Grieco3, M. Pompili3

  • Abstract Number: PB0088

    Adaptation of fixed prothrombin complex concentrate dosing for vitamin K antagonist-related bleeding in the Netherlands

    R. Abdoellakhan1, K. Meijer1, E. Roelofsen2, V. van de Craats3, N. Khorsand4

  • Abstract Number: PB1154

    Additional Risk Factors of Hereditary Thrombophilia in the North-Western Region of Russia

    V. Soldatenkov1, O. Soldatenkova1, N. Mineeva1, S. Kapustin1, L. Papayan1, N. Silina1, A. Chechetkin1, K. Komissarov1

  • Abstract Number: PB0574

    Adherence to Prophylaxis and Recording of Home-treatment Following a Switch to Extended Half-life Clotting Factor Concentrate

    M. O'Donovan1,2, C. Bergine1, N. Larkin1, E. Singleton1, J. Benson1, F. McGroarty1, L. Jeffrey3, R. Bird1, C. Buckley1, K. Ryan1, J.S. O'Donnell1, N.M. O'Connell1,2

  • Abstract Number: PB0168

    Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD)

    L. Khider1, B. Planquette1, A. Le Berre2, S. Soudet3, G. Pernod4, R. Le Mao5, M. Besutti6, N. Gendron1, A. Yannoutsos2, D.M. Smadja1, G. Goudot1, T. Mirault1, E. Messas1, J. Emmerich2, F. Couturaud5, G. Ferretti4, M.-A. Sevestre3, N. Meneveau6, G. Chatellier1, O. Sanchez1

  • Abstract Number: PB0675

    Administration of fVIII Protein through Human Placental Cells Reduces the Risk of an Antibody Response in Juvenile Sheep

    B. Trevisan1, M. Rodriguez1, S. George1, J. Shields2, S. Lankford1, R. Combs3, M. Gautreaux4, J. Owen3, A. Atala1, C.B. Doering2, H.T. Spencer2, C.D. Porada1, MG. Almeida-Porada1

  • Abstract Number: PB0530

    Adoption of Emicizumab for Hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders Survey

    E. Krumb1, K. Fijnvandraat2, M. Makris3, F. Peyvandi4,5, A. Ryan6, A. Athanasopoulos6, C. Hermans1

  • Abstract Number: LPB0008

    ADP-induced Platelet-associated Tissue Factor Expression: Unique Involvement of the P2Y12 Receptor and Modulation by Clopidogrel Treatment

    M. Brambilla1, P. Canzano1, G. Rovati2, N. Cosentino1, A. Becchetti1, J. Campodonico1, M. Cattaneo3, D. Trabattoni1, C. Pinna2, E. Tremoli1, M. Camera2

  • Abstract Number: OC 37.3

    Affimers Modulate GPVI Interactions with Collagen/Fibrinogen and GPVI-mediated Platelet Aggregation

    R.-G. Xu1, L.T. Cheah1, L. Adams2, C. Tiede2, J.S. Gauer1, A. Slater3, C. Duval1, D. Tomlinson2, K. Naseem1, A.B. Herr4, S.P. Watson3, R.A.S. Ariëns1

  • Abstract Number: PB0270

    After the Storm; 6-month Follow up Outcomes and Management of COVID-19 Related Venous Thromboembolism

    M. Ahmed1, R. Khan1, E. Xenou1, M. Fowler1, S. Sinha1, A. Lokare1, C. Kartsios1

  • Abstract Number: PB0909

    Age-specific Changes in von Willebrand Factor Multimers in Healthy Children and Adults

    N. Letunica1, S. Van Den Helm1, R. Barton1,2,3, V. Karlaftis1,2, P. Monagle3,2,1, V. Ignjatovic2,1.

  • Abstract Number: PB0907

    Agglomeration and then Capture within 10 ms Creates Shear-induced Platelet Aggregation Controlled by von Willebrand Factor Concentration

    Z. Liu1, C. Bresette1, C. Aidun1, D. Ku1

  • Abstract Number: PB1179

    Agreement between Physician and Nurse Derived Wells Score as Part of the Assessment of Deep Vein Thrombosis in a Rapid Access Ambulatory Clinic

    C. Martínez1,2, B. Rossignol3, M. Zwetkow3, V. Tagalakis1,4

  • Abstract Number: OC 33.2

    AI_PREMie: A Novel Risk Stratification Tool for Preeclamptic-toxaemia

    P.B. Szklanna1,2, S. Whoriskey3, S. Rajakumar1,2, J. Curran4, B. MacNamee5, S.P. Comer1,2, J. O’Loughlin6, C. Murphy1,7, D. O’Reily1,6, C. Windrim8,9, O. Edebiri10, A. O’Reily6,11, J. Donnelly6,11,12, N. O’Gorman10,13, M. Higgins8,9, F. Ní Áinle1,6,10,12, P.B. Maguire1,2

  • Abstract Number: PB0623

    AKATSUKI Study: A Prospective, Multicenter, Phase IV Study to Evaluate the Safety of Emicizumab Under and Immediately After Immune Tolerance Induction (ITI) Therapy in Persons with Congenital Hemophilia A (PwHA) with Factor (F) VIII Inhibitors

    T. Matsushita1, N. Suzuki1, A. Nagao2, C. Nagae3, H. Yamaguchi-Suita4, Y. Kyogoku4, A. Ioka4, K. Nogami5

  • Abstract Number: LPB0092

    Alteration of the Circulating Plasma Proteome by FXa Inhibition in Venous Thromboembolism and the Relationship with Clinical Outcome

    A. Pallares Robles1, V. ten Cate1,2, A. Schulz2, J.H Prochaska1,2,3, S. Rapp2, T. Köck2,3, S. Heitmeier4, S. Schwers4, K. Leineweber4, H.A. Ghofrani5, F.J. Meyer6, C. Espinola-Klein7, K.J. Lackner8,3, T. Münzel7,3,9, S.V. Konstantinides9,10, P.S. Wild1,2,3

  • Abstract Number: PO129

    Alterations of the Coagulation Profile in Peruvians Admitted for Pneumonia due to SARS-COV2: Cross-sectional Study

    R. Pichardo Rodriguez1,2, W. Peña-Oscuvilca1, L. Cordova-Cueva3, O. Ruiz-Franco2, F. Garmendia-Lorena2

  • Abstract Number: PB0082

    Altered Hemostasis and Complement in Pediatric Patients Treated with Cardiopulmonary Bypass

    K. Todd Jr.1, J. Tweddell1, S. Jodele1, E. Mullins1, J. Palumbo1

  • Abstract Number: PB0820

    Altered Hemostatic Potential in Adults with Primary ITP

    T. Schramm1, J. Machacek1, M. Fillitz2, B. Dixer2, D. Mehic1, S. Koder1, C. Ay1, I. Pabinger1, J. Gebhart1

  • Abstract Number: OC 15.2

    Altered Platelet Proteome and Platelet-leukocyte Interactions in Patients with COVID-19

    L. Goudswaard1, C. Williams1, F. Hamilton2, D. Arnold2, A. Davidson1, A. Poole1, I. Hers1

  • Abstract Number: PB0159

    Altered Protein S Activity Contributes Significantly to COVID-19 Pro-thrombotic State

    T. Nguyen1, D. Melancon1, M. Dean2, A. Zea3, S. Chatterjee1, J. Harman1, V. Pilli1, R. Nossaman4, J. Ochoa4, A. Ochoa2, R. Majumder1

  • Abstract Number: OC 24.4

    Altered vWF-FVIII Binding Modulates the Factor VIII Immune Response

    S.M. Zintner1, R.J. Davidson1, A.R. Wilhelm1, R.M. Camire1,2,3, L.A. George1,3,2

  • Abstract Number: LPB0116

    An Accurate and Simple Liquid Chromatography Tandem Mass-spectrometric Method for the Quantification of Emicizumab in People with Hemophilia A

    A. Donners1, L. Gerencsér1, K. van der Elst1, K. Fischer1, R. Urbanus1, M. El Amrani1

  • Abstract Number: PB0737

    An Assessment of Some Inflammatory and Haemostatic Proteins as Biomarkers for Vaso-occlusive Crises in Sickle Cell Anaemia Patients

    O. Izuegbuna1, I. Durotoye2, H. Olawumi2, I. Okpala3, K. Ernest2

  • Abstract Number: NUR 01.1

    An Exploration of Venous Thromboembolism (VTE) Prophylaxis Administration Practices across a Hospital Network

    J. Chong1, F. Gad2

  • Abstract Number: PO178

    An Insilco Approach to Venous Thromboembolism (VTE) Using Network Based Medicine with Direct Oral Anticoagulants (DOACs)

    A. Khan1,2, M.J. Khan1

  • Abstract Number: LPB0093

    An Overall Evaluation of the Adjusted Version of Global Antiphospholipid Syndrome Score (aGAPSS) on Primary Obstetric Antiphospholipid Syndrome (POAPS) Patients

    G. de Larrañaga1, F. Aranda1, S. Perés Wingeyer1, S. Udry1,2, S. Morales Perez3, C. Belizna4, J. Alijotas-Reig5, E. Esteve-Valverde3, D.S. Fernández Romero2, J. Latino2

  • Abstract Number: PB0999

    An Oxidative Stress-induced Platelet-associated Tissue Factor Expression Characterizes Patients with Migraine and Patent Foramen Ovale

    P. Canzano1, D. Trabattoni1, M. Brambilla1, B. Porro1, A. Becchetti1, S. Fiorelli1, E. Tremoli1, M. Camera1,2

  • Abstract Number: PB0300

    Analysing Risk Factors for Thrombosis in Covid-19 and Cancer Patients

    B. Obispo Portero1, J. Rogado1, G. Serrano1, C. Pangua1, A. Lopez1, A. Martin1, M. Perez1, M.A. Lara1

  • Abstract Number: PB0072

    Analysis of Coagulation Factors in Fresh-frozen Plasma

    M. Pikta1,2, T. Szanto3, R. Reimal4, P. Muliin4, H. König5, G. Blinova5, V. Banys6

  • Abstract Number: PO140

    Analysis of Hospitalization Factors of Hemophilia: 12 Years of Experience in a Single Center

    C. Qu1, F. Xue1, W. Liu1, L. Chen1, L. Zhang1, R. Yang1

  • Abstract Number: PB0786

    Analysis of Novel Risk Factors for Arterial or Venous Thrombosis in Neonates

    K. Bhatia1, S. Solanki2, A.KC Chan3, B. Paes3, M.D Bhatt3

  • Abstract Number: PO185

    Analysis of Risk Factors for Hemorrhagic Complications of Anticoagulant Therapy

    N. Vorobyeva1,2, A. Shchapkov2, E. Melnichuk2

  • Abstract Number: PB0481

    Analysis of the Percentage of Persons with Severe Hemophilia A as an Indicator of Care

    E. Tootoonchian1, J. Stonebraker2, M. El Ekiaby3, E. Gouider4, A. Iorio5, M. Makris6, J. O'Hara7, M. Recht8, G. Pierce1, D. Coffin1

  • Abstract Number: PB0385

    Analytical Performance of the Novel Haema T4 Thromboelastograph

    M. Schoorl1, T. Jansen1, J. van Pelt2

  • Abstract Number: PB0358

    Analytical Performances of a New Immunoturbidimetric D-Dimer Assay

    L. Talon1, V. Fourneyron1, A. Trapani1, T. Sinegre1, A. Lebreton1,2

  • Abstract Number: PB0204

    Anemia and Enhancement of Coagulation Are Associated during Severe COVID-19 Infection

    T. Helin1, M. Lemponen1, T. Lahtiharju1, R. Lassila2, L. Joutsi-Korhonen1

  • Abstract Number: LPB0043

    Annexin A2-mediated Surface Fibrinolysis Is Impaired in Non-alcoholic Steatohepatitis (NASH) Cirrhosis and May Contribute to Portal Vein Thrombosis

    H.I Lim1, B. Fortune2, M.T DeSancho1, K.A Hajjar3,4

  • Abstract Number: PB1029

    Annexin V Binding Detects Platelet Procoagulant Commitment but Is Not Sensitive to Reductions in the Level of Platelet PS Exposure

    S. Millington-Burgess1, M. Harper1

  • Abstract Number: PB1294

    Antepartum Anemia and Risk of Postpartum Hemorrhage: A Comprehensive Review of the Literature

    H. Glonnegger1, L. Lancaster2, R. Barnes2, A. von Drygalski2,3

  • Abstract Number: PB0135

    Anti TFPI for Hemostasis Induction in Patients with Rare Bleeding Disorders, an ex vivo Thrombin Generation (TG) Guided Study

    T. Brutman-Barazani1, E. Avishai1, I. Budnik2, A.A. Barg1, S. Levi-Mendelovich1, T. Livnat1, G. Kenet1

  • Abstract Number: OC 53.4

    Anti-ADAMTS13 Antibodies in Patients with Hereditary Thrombotic Thrombocytopenic Purpura (hTTP)

    S.R. Heeb1,2, M. Schaller1,2, E. Tarasco1,2, J.A. Kremer Hovinga1,2

  • Abstract Number: PB0316

    Anti-annexinv Serum Levels and Haematological Indices in Sickle Cell Anaemia Patients in Vasooclusive Crisis and Steady States Seen at Lagos University Teaching Hospital Lagos Nigeria

    D. Edewor-Okiyo1, A. Adediran2, A. Ogbenna1, O. Olowoselu1, A. Omolade3, S. Idogun3

  • Abstract Number: PB0769

    Anti-cancer Activity of Tempeh – Spermine Can Induce the Necrosis of HeLa Cells

    H. Sumi1, T. Mitsuo2, C. Yatagai1

  • Abstract Number: PB0280

    Anti-coagulant Drugs among Moderate, Severe and Critically Ill COVID 19 Patients in the Second Referral Hospital in Surabaya

    P.Z. Romadhon1, S.D. Suryantoro1, C. Windradi1, B.A. Mahdi1, E.D. Agustin1, D. Novendrianto1, K.N. Widiastuti1, M. Savitri1, P.N.A. Amrita1, M Noordiansyah1, S. YB1, A. Ashariati1

  • Abstract Number: OC 66.2

    Anti-cysteine/Spacer Autoantibodies that Open the Conformation of ADAMTS13 Are a Common Feature of the Autoimmune Response in Immune-mediated Thrombotic Thrombocytopenic Purpura

    L. De Waele1, A. Curie1,2, K. Kangro1,3, E. Tellier4, G. Kaplanski4,5, A. Männik3, C. Tersteeg1, B.S. Joly6, P. Coppo7, A. Veyradier6, S.F. De Meyer1, E. Roose1, K. Vanhoorelbeke1

  • Abstract Number: PB0184

    Anti-factor Xa Activity after Intermediate Dose Nadroparin for Thrombosis Prophylaxis in Critically Ill COVID-19 Patients with and without Acute Kidney Injury

    R. Eck1, J. van Leur2, M. Lukens1, W. Bult1, R. Gans1, K. Meijer1, F. Keus1

  • Abstract Number: PO162

    Anti-lymphoma Therapy Improves Thrombocytopenia in a Young Patient with Hodgkin Lymphoma: A Case Report

    M. Yang1, Z. Zhou2

  • Abstract Number: PB0748

    Anti-platelet Drugs and Risk of Intracranial Hemorrhage in Patients with Metastatic Brain Tumors

    E. Miller1, R. Patell2, E. Uhlmann3, S. Ren4, H. Southard2, P. Elavalakanar2, G. Weber5, D. Neuberg4, J. Zwicker2

  • Abstract Number: OC 70.2

    Anti-thrombotics and Anti-hypertensives with Direct Action against SARS-CoV-2

    M. Brennan1, A. Chubb1

  • Abstract Number: PB0262

    Anticoagulant Response to Tailored Low Molecular Weight Heparin Regimens in Patients with COVID-19 Infection

    A. Artoni1, V. De Zan1, M. Boscarino1, C. Novembrino1, E. Scalambrino1, S. Aliberti2, M. Panigada3, I. Martinelli1, A. Tripodi1, F. Peyvandi1,4

  • Abstract Number: PB1118

    Anticoagulant Therapy and Related Bleeding Complications in Internal Medicine Wards

    M.T. Sartori1, F. Boscaro1, A. Bozzolin1, C. Zurlo1, F. Fabris1

  • Abstract Number: PB0370

    Anticoagulated Patients Exhibit Intact Endogenous Thrombin Potential Using ST Genesia Unlike the Calibrated Automated Thrombogram

    T. Helin1, M. Lemponen1, R. Lassila2, L. Joutsi-Korhonen1

  • Abstract Number: PB0086

    Anticoagulation and Antiplatelet Management during the Perioperative Period: A Daily Practice Cohort Prospective Study

    O. Duranteau1, A. Hamriti1, T. Tuna1, B. Ickx1, L. Van Obbergh1

  • Abstract Number: NUR 01.6

    Anticoagulation Stewardship – Time To Formalize the Role?

    V. Silvari1, A. Delaney1, C. O'Leary1, S. McCarthy2, D. Lynch1, M. Crowley1

  • Abstract Number: PB0202

    Anticoagulation Strategies and Risk Of Bleeding Events in Critically ill COVID-19 Patients

    C. Gabara1, B. Solarat2, P. Castro1,3, S. Fernández1,3, J.R. Badia2, D. Toapanta4, S. Schulman5, J.C. Reverter6, A. Soriano7, J. Moises2, J. Aibar1

  • Abstract Number: PB1244

    Anticoagulation Strategies during Conditioning-induced Thrombocytopenia in Hematopoietic Cell Transplant Patients with Venous Thromboembolism

    K. Martens1, C. Amos2,3, C. Rojas Hernandez4, P. Kebriaei5, R. Basom6, C. Davis6, M. Kesten6, M. Carrier7, D. Garcia8, S. Lee6,9, A. Li6,10

  • Abstract Number: PB0230

    Anticoagulation with Tinzaparin in COVID-19 Patients in ICU: Are Low Anti-Xa Levels Associated with the Development of Thrombo-embolic Events?

    R. Van Lancker1, S. Demeester2, K. Jochmans2, M. Mekeirele1

  • Abstract Number: PB0728

    Antigenic Levels of von Willebrand Factor Predict Complications and Mortality in Patients with Liver Cirrhosis

    M. El Horri1, I. Khachaa1, A. Cheikh Khelifa1, A. Berrah1, M. Baghdadi1, A. Moueden2, D. Benlaldj2, F. Seghier2

  • Abstract Number: PB0998

    Antiplatelet Activity Produced by Chloroacilhidroquinones via Inhibition of the Mitochondrial Bioenergy

    E. Fuentes1, D. Méndez1, I. Palomo1, M. Alarcón1, F.A. Urra2, A. Trostchansky3, J.P. Millas-Vargas4, R. Araya-Maturana4

  • Abstract Number: PB0754

    Antiplatelet and Cytostatic Properties of Nilotinib Synthetic Analogues

    L.M. Pechlivani1, N. Ntemou2, P. Voulgari2, D. Pantazi1, K. Skobridis2, A.D. Tselepis1

  • Abstract Number: PB1033

    Antiplatelet Effect of Nobiletin Is Mediated by Activation of DP1 Receptor

    V. Shpakova1, A. Avdeeva2, S. Gambaryan1, N. Rukoyatkina1

  • Abstract Number: PB1246

    Antithrombotic Management of Patients with Deep Vein Thrombosis and Venous Stents: An International Registry

    A. Cervi1, D. Applegate2, S.M. Stevens2,3, S.C. Woller2,3, L. Baumann Kreuziger4, K. Puchhalapalli4, T.-F. Wang5, R. Lecumberri6, S. Schulman7,8, G. Foster9,10, J. Douketis1

  • Abstract Number: OC 60.2

    Antithrombotic Potential of a Single-domain Antibody Enhancing the Anticoagulant Activity of Protein S

    J.-C. Sedzro1, F. Adam1, A. De Carvalho1, E. Bianchini1, I. Peyron1, S. Gandrille2, S. Thomassen3, T.M. Hackeng3, O.D. Christophe1, P.J. Lenting1, C.V. Denis1, D. Borgel1,4, F. Saller1

  • Abstract Number: PB1260

    AntiXa Heparin Dosing Protocol Evaluation at a Large Academic Medical Center

    T. Ahuja1, M. Williams1, S. Arnouk1, D. Lum1, J. Papadopoulos1, V. Raco2, D. Green1

  • Abstract Number: PB0622

    AOZORA Study: Long-Term Safety and Joint Health in Pediatric Patients with Hemophilia A without FVIII Inhibitors Receiving Emicizumab – Protocol for a Multicenter, Open-label, Phase IV Clinical Study

    M. Shima1, H. Takedani2, K. Kitsukawa3, M. Taki4, A. Ishiguro5, A. Nagao6, H. Yamaguchi-Suita7, Y. Kyogoku7, S. Yoshida7, K. Nogami1.

  • Abstract Number: OC 71.2

    Apolipoprotein A-IV Polymorphisms Q360H and T347S Reduce its Inhibitory Effect against Thrombosis

    D. MacKeigan1,2,3, S.-Y. Yu2,4, A. Shoara5, M. Neves2,3,6,7, P. Chen2,3,7, C. Shen2,3,6, P. Bhoria2,3,6, P. Johnson5, H. Ni1,2,3,6,7,8

  • Abstract Number: PB0247

    Apparent Different of Lupus Anticoagulant Disappearance in Novel Coronavirus 2019 Patients as a Distinct Clinical Feature

    H. Kim1, M.-S. Kim2, S. Jang1

  • Abstract Number: PB0406

    Application of the ISTH-BAT In Congenital Fibrinogen Disorders

    S. Mohsenian1, O. Seidizadeh2, A. Azarkeivan1, M. Jazebi3, S. Moazezi3.

  • Abstract Number: PB1075

    Appropriate dose of Dabigatran in Asian Population

    N. Hantrakun1, W. Wongcharoen1, K. Thiankhaw1, L. Norasetthada1, A. Tantiworawit1, E. Rattaritamrong1, T. Rattanathammethee1, S. Huntrakool1, P. Piriyakhuntorn1, C. Chai-Adisaksopha1

  • Abstract Number: PB1162

    Appropriateness of Thrombophilia Evaluation and Anticoagulation Management: A Multi-specialty Survey of Practitioners at Tower Health Reading Hospital

    T. Johnson1, D. Forman1

  • Abstract Number: OC 33.4

    Are Antiphospholipid Antibodies a Poor Prognostic Factor for HELLP Syndrome?

    M. Pécourt1, C. Yelnik2, L. Ghesquière3, E. Drumez4, E. Cailliau4, E. Hachulla2, V. Debarge3, N. Morel5, V. Le Guern5, C. Garabedian3, N. Costedoat-Chalumeau5, M. Lambert2

  • Abstract Number: PB0058

    Are Direct Oral Anti-Xa Inhibitors Absorbed in Cancer Patients after Gastrectomy? A Case Series

    H.C. Puhr1, A. Ilhan-Mutlu1, P. Quehenberger1, P.A. Kyrle1, S. Eichinger1, L. Eischer1

  • Abstract Number: PB0173

    Are Mild or Moderate COVID-19 Patients at Higher Risk of VTE? A Comparison of Two Prospective European Cohorts in Emergency Departments

    D. Douillet1,2, J. Riou3,4, A. Penaloza5, T. Moumneh1,2, C. Soulié6, D. Savary1,7, F. Morin1, R. Mahieu8,9, P.-M. Roy1,2

  • Abstract Number: PB0853

    Arginine-containing Peptides and Acetylsalicylic Acid: Evaluation of Antiplatelet Effects

    M. Grigorjeva1, T. Obergan1, T. Shubina1, L. Lyapina1

  • Abstract Number: PB1054

    Artificial Intelligence Classifies APS in Anticoagulated Patients Based on Thrombin Generation

    R. de Laat-Kremers1, D. Wahl2, S. Zuily2, M. Ninivaggi1, W. Chayoua1, V. Regnault2, J. Musial3, P. de Groot1, K. Devreese4, B. de Laat1

  • Abstract Number: PB0249

    Artificial Neural Networks to Predict Covid-19 Progression of Moderate Hospitalized Patients using Early Clinical Parameters and Blood Tests

    T.D. Martins1, S.D. Martins2, S.A.L. Montalvão2, G.Y. Ottaiano1, M. Al Bannoud1, L.Q. Silva2, S.C. Huber2, T.S. Diaz3, C.K. Wroclawski4, C.C. Filho4, R.M. Filho5, J.M. Annichino-Bizzacchi2

  • Abstract Number: PB0890

    Aspirin Resistance after Total Hip or Knee Arthroplasties

    N. van Oosterom1,2, M. Barras1,2, N. Cottrell1, R. Bird2

  • Abstract Number: LPB0072

    Aspirin vs P2RY12-Inhibitors to Reduce Cancer Associated Thrombosis and Tumor Growth in Digestive Cancers

    A.L. Palacios Acedo1, S. Mezouar1, D. Mege1,2, L. Crescence1, C. Dubois1, L. Panicot-Dubois1

  • Abstract Number: OC 15.4

    Assessing Complement Activation in COVID-19 Predicts Hypoxemia and Mortality

    A. Leatherdale1,2, S. Stukas3,4, V. Lei1,2, H. West1,3, C.J. Campbell5, R.L. Hoiland6,7, J. Cooper3,4, C.L. Wellington3,4, M. Sekhon8, E.L.G. Pryzdial1,3,9, E.M. Conway1

  • Abstract Number: OC 63.1

    Assessing the Clinical Probability of Pulmonary Embolism during Pregnancy: The Pregnancy-Adapted Geneva (PAG) Score

    H. Robert-Ebadi1, A. Elias2, O. Sanchez3, E. Le Moigne4, J. Schmidt5, C. Le Gall6, D. Aujesky7, P.-M. Roy8, T. Moumneh9, C. Chauleur10, F. Rouyer11, G. Le Gal12, M. Righini1

  • Abstract Number: OC 72.3

    Assessing the Pharmacodynamics of RUC-4 (Zalunfiban), a Novel αIIbβ3 Antagonist, Using VerifyNow Assays in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Treated with Aspirin and Ticagrelor

    O.S. Bentur1, W.L. Bor2, K.L. Zheng2, A.H. Tavenier3, A. van ’t Hof4, J.M. ten Berg2,4, B.S. Coller1

  • Abstract Number: PB1227

    Assessing Use of Surrogate Outcome Measures in Randomized Controlled Trials Investigating Venous Thromboembolism Prophylaxis

    A. Eshaghpour1, A. Li2, J. Park3, T. Cho3, M. Crowther4

  • Abstract Number: PB0421

    Assessment of DOACs Effect on Clot Formation and Fibrinolysis Using the FibWave

    J. Evrard1, V. Maloteau1, J.M. Dogné1, J. Douxfils2

  • Abstract Number: PB0384

    Assessment of Low Response Rates to P2Y12 Inhibition in Cardiology Patients: Comparison of the VerifyNow P2Y12 and Anysis-P2Y12 Assay

    S. Shin1, J. Piao1, Y.-W. Whang2, C.U. Choi2.

  • Abstract Number: PB0349

    Assessment of Sample Stability after Freezing on ST Genesia System Using the STG-BleedScreen Application

    J. Mullins1, D. White1, A. Carlo2, S. Cox-Morton1, S. Mac Donald1

  • Abstract Number: PB0528

    Assessment of the Bleeding Phenotype in Patients with Non-severe Hemophilia According to the ISTH Bleeding Assessment Tool (BAT)

    F. Kloosterman1, A. Zwagemaker1, S.C. Gouw1,2, C.N. Bagot3, P. Brons4, M. Cnossen5, P. Collins6, S. Jackson7, K. Meijer8, M.J.H.A. Kruip9, F.W.G. Leebeek9, B. Laros-van Gorkom10, C. Male11, I. Pabinger12, S. Shapiro13, M. Coppens14, J.G. van der Bom15, K. Fijnvandraat1,16, DYNAMO Study Group

  • Abstract Number: PB0989

    Assessment of the Effects of Syk and BTK Inhibitors on GPVI-mediated Platelet Signaling and Function

    T. Zheng1, E. Lofurno2, A. Melrose1, H. Lakshmanan1, J. Pang1, K. Phillips3, M. Fallon1, T. Kohs1, A. Ngo1, J. Shatzel1, M. Hinds1, O. McCarty1, J. Aslan1

  • Abstract Number: PB1309

    Assessment of the Utility of the Pregnancy-adapted YEARS Algorithm in Predicting Presence of Pulmonary Embolism (PE) in Pregnant Women (PA-PE)

    A. Alexander1, E. Treharne1, E. jackson1, B. Myers2

  • Abstract Number: PB0592

    Assessment of Thrombin Generation on Severe Haemophilia A Patients in the Clinical Laboratory

    J. Mullins1, D. White1, S. Cox-Morton1, A. Marin2, M. Gironella2, F. Bosch2, S. Franco2, A. Tosetto3, S. Mac Donald1

  • Abstract Number: PB0417

    Assessment of Сardiometabolic Biomarkers in Young Adults with Normal Body Weight and Obesity

    V. Chulkov1, E. Gavrilova1, V. Chulkov1, N. Vereina1, S. Sinitsin1, S. Martynov1, P. Tkachenko1, E. Lenets1

  • Abstract Number: PB0868

    Assigning Pathogenicity to a Novel de Novo ACTN1 Variant in a Child with Macrothrombocytopenia: A Case Description And Review of Previously Identified Variants

    L. FitzGibbon1, V. Bouskill2, M. Carcao2, L. Li3, F.G Pluthero3, W.H. Kahr2,3,4, S.K Westbury1,3

  • Abstract Number: PO125

    Associated Factors of Adherence to the Use of Coumarin Derivatives or Direct Oral Anticoagulants: Protocol of a Systematic Review

    W. Sousa1,2, N. Guimarães1, C. Viana1, P. Machado1, A. Medeiros1,3, M. Vianna1, M.A. Martins1,2,3

  • Abstract Number: PB1101

    Association between Cancer and Anatomical Site of Venous Thromboembolic Disease

    D. Froehling1, W. Wysokinski1, R. McBane1, D. Houghton1, D. Vlazny1, D. Hodge2, L. Peterson1, A. Casanegra1

  • Abstract Number: PB1193

    Association between Cardiovascular Risk Factors and Venous Thrombosis in the Elderly

    H. Wang1, M. Cushman2, F.R Rosendaal1, A. van Hylckama Vlieg1

  • Abstract Number: PB0476

    Association between Factor VIII Deficiency and Low Bone Mineral Density in Children with Hemophilia

    O.U. Galindo-Aguilar1, P.A. García-Hernández2, J.Á. Garza3, D. Garay-Mendoza4, M. Ortiz-Castillo5, A. González-Martínez5, A.J. Bautista-Gómez5, G. González-Martínez5, J.F. Molina-de la Garza5, L. Villarreal Martínez5

  • Abstract Number: PO127

    Association between FGB – 455 G/A and PAI-1 – 675 5G / 4G Gene Polymorphisms and Covid-19 Severity

    B. Vatseba1, N. Virstyuk1

  • Abstract Number: LPB0142

    Association between Non-O Blood Group and the Risk of Venous Thromboembolism due to Oral Contraceptive Therapy

    A. Poretto1, L. Spiezia1, G. Turatti1, M. Marobin1, E. Borella1, E. Campello1, D. Tormene1, P. Simioni1

  • Abstract Number: LPB0048

    Association between Plaque Vulnerability and Neutrophil Extracellular Traps (NETs) Levels: The Plaque at RISK Study

    J.J. de Vries1, A.S. Autar1, D.H. van Dam-Nolen1, S.J. Donkel1, M. Kassem2, A.G. van der Kolk3,4, T.J. van Velzen5, ME. Kooi2, J. Hendrikse4, P.J. Nederkoorn5, D. Bos1, A. van der Lugt1, M.P. de Maat1, H.M. van Beusekom1

  • Abstract Number: PB0271

    Association between Race and the Incidence of Thrombosis in Hospitalized COVID-19 Patients Across a New York City Hospital System

    P.P. Theprungsirikul1, S.E. Saith1

  • Abstract Number: PB1240

    Association of Adding Antiplatelet Therapy to Warfarin for Management of Venous Thromboembolism with Bleeding and Other Adverse Events

    M. Song1, B. Haymart1, X. Kong1, M. Ali2, J. Kozlowski3, G. Krol4, S. Kaatz4, J. Froehlich1, G. Barnes1

  • Abstract Number: OC 06.4

    Association of Anticoagulation Resumption and Repeat Imaging on Venous Thromboembolism Recurrence after Allogeneic Hematopoietic Cell Transplantation (HCT)

    K. Martens1, C. Amos2,3, C. Rojas Hernandez4, P. Kebriaei5, R. Basom6, C. Davis6, M. Kesten6, M. Carrier7, D. Garcia8, S. Lee6,9, A. Li6,10

  • Abstract Number: PO189

    Association of Complete Blood Parameters, D-dimer and Lupus Anticoagulant with VTE Risk Score in Hospitalized Patients

    E. Ezigbo1, I. Isiwu2, L. Nnamani2, T. Nwagha3

  • Abstract Number: PB0256

    Association of Elevated D-dimers with Severity and Outcome of Covid-19 Infection in Children

    N. Saqlain1, N. Mazher1, A. Bari1, A. Ch1, S. Farhan1, N. Ahmed1

  • Abstract Number: LPB0139

    Association of FXI Activity with Thrombo-inflammation, Extracellular Matrix Interactions, Lipid Metabolism and Apoptosis in Venous Thromboembolism

    A. Pallares Robles1, V. ten Cate1,2, A. Schulz2, J.H. Prochaska1,2,3, S. Rapp2, T. Köck2,3, M. Panova Noeva1,2, S. Heitmeier4, S. Schwers4, K. Leineweber4, H.-J. Seyfarth5, C.F. Opitz6, H. Spronk7, C. Espinola-Klein8, K.J. Lackner9,3, T. Münzel8,3,10, M.A. Andrade-Navarro11, S.V. Konstantinides10,12, H. ten Cate7, P.S. Wild1,2,3

  • Abstract Number: OC 13.3

    Association of Genetic Alterations with Severity of Disease in Type III vWD Patients

    M.A. Naveed1, S. Khaliq1, S. Mohsin1, A. Abid2, U. Saleem3, A. Ammar1

  • Abstract Number: PB0616

    Association of Individual Pharmacokinetics-guided Regimen in Hemophilia A Patients and FVIII Consumption: A Single-center Study

    Q. Hong1, C. Shu Qin1, Z. Wen Jing2, H. Xiao Hua3, C. Yong Fang1, Y. Yu Hua1, X. Xing Yi4

  • Abstract Number: PB1098

    Association of KRAS Mutation with Arterial Thromboembolism in Advanced Lung and Gastrointestinal Cancer

    S. Maharaj1, S. Bhandari1, X. Wu1, S. Rai1, V. Sharma1

  • Abstract Number: PB0512

    Association of Physical Activity with Bleeding Frequency in Children with Hemophilia A: A CHESS PAEDs Study Analysis

    R. Ofori-Asenso1, F. Nissen2, M. Silkey2, T. Xu2, H. Yamaguchi-Suita3, D. Nosaka3, M. Aizenas2, O. Meier2, T. Burke4,5, J. O'Hara4,5

  • Abstract Number: PB0753

    Association of Platelet Count and Coagulopathy before, during and Post Chemotherapy: Is it Worth Doing?

    N. Anwar1, N. Fatima1, H.-u. Mujtaba1, T. Shamsi1

  • Abstract Number: PB1069

    Association of Retest Interval with INR Control in Warfarin Patients with Markedly Out of Range INRs

    B. Haymart1, X. Kong1, G.D Barnes1, A. Purohit1, M. Ali2, E. Kline-Rogers1, J.H Kozlowski3, G. Krol4, V. Shah4, J.B Froehlich1, S. Kaatz4

  • Abstract Number: OC 76.2

    Association of Single Nucleotide Polymorphisms with Major Bleeding Risk during Vitamin K Antagonists Treatment: A Case-cohort Study

    E. Camilleri1, M.H.A. Bos2,3, P.H. Reitsma2,3, F.J.M. van der Meer2, J. Swenn4, S.C. Cannegieter1,2,3, N. van Rein4,5

  • Abstract Number: PB0144

    Association of the Angiopoietin/Tie2 and VEGF-A Pathways with clinical and Laboratory Markers of Disease Severity in COVID-19

    C.R.P. Moraes1, F. Lima1, I.T. Borba Junior1, M.S. Barbosa1, L.C Ribeiro1, A.C Palma1, R.G Ulaf1, A.F. Bernardes1, E. Mansour1, F.T.M. Costa2, F.A. Orsi1, J.M Annichino-Bizzacchi1,3, M.L. Moretti1, L.A Velloso1,4, E.V. De Paula1,3

  • Abstract Number: OC 64.3

    Associations of Residual Venous Obstruction, d-Dimers, fFctor VIII and CRP with Long-term Outcomes of Deep Vein Thrombosis

    A.F. Iding1,2, B. Kremers2, A. Pallares Robles2,3, M. Pavlicic1, H. ten Cate1,2,4, A.J. ten Cate-Hoek1,2

  • Abstract Number: PB0193

    Atherothrombotic Events in Hospitalized COVID-19 Patients Are Associated with Diabetes mellitus

    D. Morozova1, K. Nezhdanov1, O. Eliseeva2, L. Minushkina3, D. Zateyshchikov3

  • Abstract Number: PB0107

    Atrial Flutter and Intracardiac Thrombus After Cardiac Surgery

    S. Karaman1, D. Gokceer Karabulut2, A. Unuvar1, S. Sahin1, K. Nisli2, D. Tugcu1, G. Tanyildiz1, R. Tuna1, M. Bilici1, Z. Karakaş1

  • Abstract Number: PB0943

    Atypical Presentation of VWD Leading to Discovery of Novel VWF Mutation

    T. van de Berg1, A.M Todaro1, J. van Beers2, K. Wichapong1, F. Heubel-Moenen3, E. Castoldi1, Y. Henskens2, E. Beckers3

  • Abstract Number: PB0828

    Autoimmune Platelet Function Disorders: Systematic Review of Acquired Glanzmann Thrombasthenia and Acquired Delta Storage Pool Disease Cases

    A. Ferretti1, M. Bacci2, M. Marchetti3, M.A. Alberelli1, A. Falanga4, C. Lodigiani5, E. De Candia6

  • Abstract Number: PB1064

    Automated Methods for the Enhancement of Lupus Anticoagulant Mixing Study Sensitivities

    Z. Cao1, R. Bottenus1, C. Kung1

Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley